Topical preparations to reduce SARS-CoV-2 aerosolization in head and neck mucosal surgery.

Harman S ParharKendall TascheRobert M BrodyGregory S WeinsteinBert W O'MalleyRabie M ShantiJason G Newman

Published in: Head & neck (2020)

While specific evidence regarding SARS-CoV-2 is lacking, PVP-I-based preparations have been successfully demonstrated to reduce viral loads of coronaviruses. They are relatively safe to use in the upper airway and may reduce risk of SARS-CoV-2 aerosolization during upper airway mucosal surgery.

Keyphrases

sars cov
minimally invasive
coronary artery bypass
respiratory syndrome coronavirus
surgical site infection
ulcerative colitis
percutaneous coronary intervention
atrial fibrillation
acute coronary syndrome